socalTECH

NOVEMBER 4, 2010

Thousand Oaks-based biotech giant Amgen said today that its nonprofit arm, the Amgen Foundation , is giving $4.5M in a grant to invest in South Los Angeles schools. Amgen said the grant goes to MLA Partner Schools, an effort which looks to prepare children from South Los Angeles for college and life.

Education 178

Education Thousand Oaks Los Angeles Angel 178

socalTECH

JANUARY 24, 2011

Thousand Oaks-based biotech giant Amgen said Monday afternoon that it is acquiring Biovex , a Woburn, Massachusetts-based developer of treatments for melanoma and head and neck cancer. BioVex develops OncoVEX, a novel oncolytic vaccine in Phase 3 clinical development. READ MORE>>.

Thousand Oaks 167

Thousand Oaks Sales Invest Capital 167

socalTECH

DECEMBER 17, 2013

Thousand Oaks-based biopharmaceuticals startup Atara Biotherapeutics announced this morning that it has raised $38.5M The funding came from Amgen Ventures, Celgene Corporation, EcoR1 Capital, plus Alexandria Venture Investments, DAG Ventures, Domain Associates, and Kleiner Perkins Caufield & Byers.

Thousand Oaks 180

Thousand Oaks Venture Capital Capital Funding 180

socalTECH

APRIL 1, 2011

Thousand Oaks-based Teledyne Technologies said this morning that it has acquired a minority stake in Optech , a developer of three dimensional, lidar-based imaging systems. Teledyne said the investment was made through its subsidiary, Teledyne DALSA. Financial details of the acquisition were not disclosed.

Thousand Oaks 145

Thousand Oaks Acquisition Invest Technology 145

socalTECH

MARCH 18, 2011

Thousand Oaks-based Teledyne Technologies said this morning that it has acquired a majority interest in Solvang-based Nova Sensors. Financial terms of the deal were not disclosed. Nova Research designs camera electronics, infrared camera systems, and integrated circuits. READ MORE>>.

Thousand Oaks 154

Thousand Oaks Research Pricing Design 154

socalTECH

JANUARY 22, 2010

invested in Southern California in Q4. was invested in Southern California, as well as Q4 of last year, when $508.2M was invested in the region. However, nationally, venture capital numbers were much worse, with venture investments dropping to the lowest level in more than a decade. in investments. in investments.

Southern California 113

Southern California Invest Venture Capital Orange County 113

socalTECH

APRIL 24, 2012

Amgen Ventures , the venture capital arm of Thousand Oaks-based Amgen , has re-upped on an investment in a biopharmaceuticals developing microRNA-based treatments for cardiovascular and muscle disease. and Broadview Ventures. miRagen is based in Boulder, Colorado.

Thousand Oaks 150

Thousand Oaks Venture Capital Invest Capital 150

socalTECH

JANUARY 10, 2014

Thousand Oaks-based Atara Biotherapeutics announced this morning that it is in a second close of its Series B funding round, bringing its total raised in the funding to $52M.

Thousand Oaks 147

Thousand Oaks Capital Funding Invest 147

socalTECH

JUNE 12, 2012

Thousand Oaks-based Teledyne Scientific and Imaging has been awarded $2.1M, as part of a major investment from the U.S. Department of Energy announced Tuesday, to bolster innovative manufacturing technology in the United States.

Thousand Oaks 145

Thousand Oaks Invest Technology Help 145

socalTECH

JANUARY 9, 2017

Thousand Oaks-based Amgen is the lead investor in a round for San Francisco- and Bozeman, Montana-based SiteOne Therapeutics , SiteOne said on Friday. SiteOne said it raised $15M in a Series B funding round, which was led b Amgen, and also included Next Frontier Capital and insiders.

Thousand Oaks 100

Thousand Oaks Invest Capital Funding 100

socalTECH

JANUARY 9, 2017

Thousand Oaks-based Amgen announced this morning that it has made a $30M investment in a German company developing cancer immunotherapy, Immatics Biotechnologies GmbH. According to Amgen, the deal could potentially be worth over $1 billion in milestone payments plus royalties.

Thousand Oaks 100

Thousand Oaks Invest Platform Develop 100

socalTECH

JULY 30, 2018

Thousand Oaks-based Amgen has returned as one of the investors in cancer therapeutis developer Sutro Biopharma , as part of an $85.4M funding round. South San Francisco-based Sutro Biopharma said last week that it has raised $85.4M in a Series E funding round.

Thousand Oaks 100

Thousand Oaks Invest Capital Funding 100

socalTECH

APRIL 8, 2014

Thousand Oaks-based drug development company Atara Biotherapeutics announced this morning that it has added Matthew K. Fust as a board member, and hired Mitchall G. Clark as its Chief Regulatory and Quality Assurance Officer.

Thousand Oaks 138

Thousand Oaks Invest Capital Funding 138

socalTECH

JANUARY 4, 2019

Atara Biotherapeutics , the biopharmaceuticals firm which has its manufacturing and research efforts based in Thousand Oaks, said on Thursday that its current President and CEO, Isaac Ciechanover, M.D., The company is based in South San Francisco, but was founded in Thousand Oaks and has a large facility in the city.

Thousand Oaks 113

Thousand Oaks Research Invest Capital 113

socalTECH

NOVEMBER 17, 2017

Amgen Ventures , the venture investment arm of Thousand Oaks-based Amgen , is one of the new investors in precision oncology and medicine startup Syapse.

Thousand Oaks 113

Thousand Oaks Funding Software Capital 113

socalTECH

OCTOBER 23, 2015

Thousand Oaks-based SunBrite TV , a manufacturer of large screen, HDTV screens specifically designed to be installed outdoors, next to pools, on patios, and elsewhere, has been acquired by SnapAV , which is owned by private equity investor General Atlantic. SunBrite said it was advised by Intrepid Investment Bankers on the deal.

Thousand Oaks 100

Thousand Oaks Screening Equity Acquisition 100

socalTECH

MARCH 8, 2016

Thousand Oaks-based Amgen has made another investment this morning in immunology startup Tizona Therapeutics , via its venture capital arm, Amgen Ventures. Series A investors--including Amgen Ventures--also participated, with investments from MPM Capital, Astellas Venture Management and InterWest Partners. READ MORE>>.

Thousand Oaks 100

Thousand Oaks Funding Venture Capital Invest 100

socalTECH

OCTOBER 12, 2016

Thousand Oaks-based Akriveia Therapeutics , a biotechnology startup focused on immuno-oncology, announced this morning that it has raised $7.5M in a Series A investment. The investment came from F-Prime Capital Partners.

Thousand Oaks 100

Thousand Oaks Research Activity Invest 100

socalTECH

OCTOBER 17, 2016

Thousand Oaks-based Amgen said late Friday that it has named Ellen J. Kullman to its board of directors, expanding the company's board to a total of 14 directors. Kullman is the former President, Chair, and CEO of E.I. du Pont de Nemours and Company (Dupont). READ MORE>>.

Thousand Oaks 100

Thousand Oaks Invest Technology Company 100

socalTECH

JULY 6, 2015

Thousand Oaks-based Teledyne Technologies has increased its stake in San Diego-based Ocean Aero , a developer of unmanned, robotic underwater and surface vehicles used for the scientific, defense, and oil and gas market, the company said late Friday. Teledyne made its initial investment in Ocean Aero in July of 2014.

Thousand Oaks 100

Thousand Oaks San Diego Invest Marketing 100

socalTECH

OCTOBER 9, 2015

Thousand Oaks-based Amgen has seen an exit out of its startup investment portfolio, and activities of its Amgen Ventures venture capital arm, at Berkeley-based Adheron Therapeutics this morning. Adheron said that it has been acquired by Roche , in a deal worth $105M upfront and up to $475M in additional milestone payments.

Thousand Oaks 100

Thousand Oaks Venture Capital Activity Capital 100

socalTECH

OCTOBER 22, 2015

Thousand Oaks-based Amgen , via its nonprofit arm, The Amgen Foundation , said Wednesday that it will spend more than $4M to help bring hands on biotechnology labs to schools. Amgen said that it has invested a total of more than $13 million since it launched the Amgen Biotech Experience in 1990. READ MORE>>.

Thousand Oaks 100

Thousand Oaks Funding Invest Help 100

socalTECH

AUGUST 1, 2018

Thousand Oaks-based biotech giant Amgen is expanding its footprint in Rhode Island, saying on Tuesday that it is opening a new biomanufacturing plant at its West Greenwich, R.I. According to Amgen, the new plant will manufacture products for both the U.S. and global markets.

Thousand Oaks 100

Thousand Oaks Invest Marketing Product 100

socalTECH

DECEMBER 8, 2022

Thousand Oaks-based Dantari has raised $47M in its Series A funding, saying that it has launched a new, clinical-stage biotechnology company developing targeted therapeutics for the treatment of cancers and other diseases. Dantari has appointed Richard A. Markus, M.D., a co-founding managing director at Westlake.

Westlake Village 100

Westlake Village Thousand Oaks CalTech Funding 100

socalTECH

MAY 6, 2016

Thousand Oaks-based Amgen has helped to back a new, life sciences fund, managed by San Francisco-based venBio , as an anchor supporter of a new fund. venBio did not say how much Amgen committed to the fund, which is venBio's second life sciences fund.

Thousand Oaks 100

Thousand Oaks Funding Help Technology 100

socalTECH

OCTOBER 29, 2015

I grew up in Thousand Oaks, went to USC, and we met each other way back in the 90's. Where there are lots of players focused on different types of equity, different types of investments, different types of debt, they're doing it in a very unfocused manner. Brew Johnson: It's exciting to be building this business in LA.

Southern California 100

Southern California Google Technical Review Manhattan Beach 100

SoCal Delicious

APRIL 5, 2010

• Jack Gilbert , once the chief executive officer of a large Los Angeles-based corporation, later founded Thousand Oaks Land Development and played a major role in the development of Thousand Oaks area, leading that city’s emergence as a major business and corporate center.

Santa Barbara 53

Santa Barbara Thousand Oaks Oracle Ventura 53

Xconomy

JULY 22, 2016

It’s the first partnership for Jounce, and a big one: the startup got a $225 million up front cash payment from Celgene and a $36 million equity investment. And in other Amgen news, the Thousand Oaks, CA, company filed for FDA approval of osteoporosis drug romosuzumab.

Startup 40

Startup San Diego News Thousand Oaks 40

Xconomy

AUGUST 5, 2016

—Gene therapy news: After investing in Bamboo Therapeutics and its Duchenne muscular dystrophy treatment earlier this year, Pfizer bought the Chapel Hill, NC-based biotech outright on Monday for $150 million up front , with potentially another $495 million later. . Regeneron is paying $25 million upfront.

News 40

News Thousand Oaks Pricing Report 40

socalTECH

JANUARY 5, 2017

the founding shareholder and chairman and treasurer of Thousand Oaks-based Amgen , has died, at the age of 90. Bowes founded USVP after spending nearly 25 years at investment banking firm Blyth & Co., Bowes, Jr. , Bowes--who also founded venture capital firm USVP --died peacefully in his home on December 28th.

Thousand Oaks 113

Thousand Oaks Venture Capital Capital Invest 113

socalTECH

JANUARY 27, 2020

Kobe Bryant , the basketball legend who also was one half of Los Angeles private equity investment firm Bryant Stibel , is dead at the age of 41, after a tragic helicopter crash in Calabasas took his life, the life of one of his daughters, and seven others.

Thousand Oaks 113

Thousand Oaks Legalzoom Calabasas High Tech 113

Xconomy

AUGUST 26, 2016

—Amgen (NASDAQ: AMGN ) of Thousand Oaks, CA, said that the FDA rejected its drug etelcalcetide (Parasbiv) , a treatment for patients with an excess of damaging hormone release because of chronic kidney disease. A Phase 2 trial of the drug, AMX0035, should start in late 2016 or early 2017.

Pricing 40

Pricing Thousand Oaks Startup Research 40